Promising c. diff drug trial halted early – only 3 patients enrolled
NCT ID NCT06536465
First seen Nov 17, 2025 · Last updated May 12, 2026 · Updated 17 times
Summary
This study tested a new medicine called REC-3964 to see if it could stop Clostridioides difficile infections from coming back in adults. The trial was stopped early after only 3 people joined. Researchers were checking safety and whether the drug helped people stay infection-free for 8 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT CLOSTRIDIOIDES DIFFICILE INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
GANJ - Toms River - Ocean Family Gastroenterology
Toms River, New Jersey, 08755, United States
-
Southern Star Research Institute, LLC
San Antonio, Texas, 78229, United States
Conditions
Explore the condition pages connected to this study.